Medpace reports Q1 2024 results; exhibit not provided, no specific data available

Medpace Holdings, Inc.

2024-Q1 EPS reported $3.20 revenue$511,044,000

Press release filed as Exhibit 99.1 for three months ended March 31, 2024.
No revenue, EPS, or other financial figures are extractable from the available filing text.
Filing indicates earnings announcement but actual results are not included in the provided content.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.4

Medpace Holdings, Inc. reported financial results for the three months ended March 31, 2024.

Period: the three months ended March 31, 2024
Result: reported results

Exact text from the filing

On April 22, 2024, Medpace Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2024.

View on SEC.gov

1341 earnings releases filed in the last 30 days. Browse all earnings releases →

Medpace Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001668397-24-000089

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.